pharmaphorum

JANUARY 28, 2024

The CHMP has rejected marketing approvals for two drugs from Neuraxpharm and Apellis, but the pharma companies say they will appeal

Drugs 90

Drugs Pharma Companies Marketing 90

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Other businesses such as Redhill Biopharma or Vincerx Pharma have also announced plans for large layoffs. This is particularly felt among smaller retail investors.

Marketing 324

Marketing Gene Therapy Manufacturing Pharma Companies 324

Delveinsight

SEPTEMBER 24, 2021

The present IgA Nephropathy market majorly revolves around immunosuppressants, including steroids, ACE inhibitors (angiotensinconverting enzyme inhibitors) and ARBs (angiotensin II receptor blockers). Pharma companies such as Calliditas Therapeutics AB, Chinook Therapeutics, Inc., IgA Nephropathy Pipeline Drugs.

Pharma Companies 77

Pharma Companies Marketing Protein Drugs 77

World of DTC Marketing

JANUARY 19, 2021

OPENING : DTC marketers have relied too much on TV advertising. DTC marketers have relied too heavily on TV, and now new data shows that TV glory days are quickly fading and that people feel that commercials are repeated too frequently and are irrelevant to them. New ways to reach consumers need to be explored.

Marketing 180

Marketing Pharma Companies Drugs Research 180

Drug Discovery World

NOVEMBER 11, 2022

Seven pharmaceutical companies have announced a joint initiative to reduce near-term emissions and help develop net zero health systems. . The post Pharma companies team-up to reduce emissions appeared first on Drug Discovery World (DDW). The announcement comes on the back of worsening global climate change.

Pharma Companies 95

Pharma Companies Clinical Trials Clinical Trials Trials 95

Pharmaceutical Technology

OCTOBER 2, 2023

Many pharma companies argue that Medicare’s gross spending disregards rebates, discounts and fees paid to prescription drug insurance plans.

Pharma Companies 130

Pharma Companies Drugs Marketing 130

World of DTC Marketing

APRIL 6, 2022

DTC marketing has evolved. Challenge #1 – DIGITAL MARKETING. Pharma companies are increasing digital budgets, but they are wasting too much money because of internal staffing issues and inexperience with online marketing. Paid Media – The most commonly used KPI in marketing is essentially worthless.

Marketing 196

Marketing Sales Pharma Companies Doctors 196

XTalks

OCTOBER 4, 2023

Health economics and outcomes research (HEOR) and market access strategies play a critical role in ensuring that newly approved therapies are made available to patients. Professionals in these roles are facing new challenges when it comes to negotiating coverage for many of the new, innovative treatments that are coming to market.

Marketing 105

Marketing Development Drugs Gene Therapy 105

Bio Pharma Dive

NOVEMBER 19, 2020

The deal, which has Pfizer paying as much as $70 million, is the latest in a series of moves by big pharma companies to forge a stronger position in the world's second-largest drug market.

Pharma Companies 364

Pharma Companies Marketing Drugs 364

Fossil Remedies

DECEMBER 29, 2022

There are many types of pharma businesses and one can choose any of them. Launching a pcd pharma company, for example, can be a way of reaping the benefit of pharma boom. If you are running a small business in this niche, then it is time for you to invest in any of the good pharma companies.

Pharma Companies 52

Pharma Companies Production Marketing Pharma Production 52

World of DTC Marketing

JUNE 11, 2021

Health care professionals have been critical of these agencies’ decisions during the pandemic, with some concerned that their work has been politicized and now with advisory panel members resigning as a result of the terrible decision to approve Biogen’s drug you can bet that HCPs are going o want to see a lot more clinical data.

Marketing 187

Marketing Nurses Doctors Doctor 187

BioSpace

JULY 14, 2021

?The CMA said some pharmaceutical firms charge the NHS with excessively high prices for hydrocortisone tablets and paid off potential competitors to stay out of the market.

Pharma Companies 96

Pharma Companies Regulation Drugs Marketing 96

World of DTC Marketing

MARCH 3, 2021

SUMMARY: According to Pew Internet “Despite antibiotics’ vital role in cancer care, companies have abandoned their development in favor of more profitable drugs. Drug resistance is a silent threat that could end up killing as many as 10m people in 2050. The pharma industry is warning of the consequences of inaction. “If

Marketing 174

Marketing Development Pharma Companies Drugs 174

Creogenic Pharma

APRIL 15, 2023

The Indian pharmaceutical market reached a value of around $27 billion by the end of 2017 and is predicted to experience a CAGR of over 5% for the next five years, reaching over $60 billion by 2022. India is a major player in the global pharmaceutical industry, accounting for almost 20% of the export volume of generic drugs worldwide.

Pharma Companies 40

Pharma Companies Production Manufacturing Generic Drugs 40

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. They relied so much on a new drug that they tried to market a product with bad science behind it.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

Pharma Packaging Solutions

OCTOBER 6, 2021

Over the years, more and more pharmaceutical companies have moved away from in-house packaging operations and toward pharmaceutical contract packaging. There are plenty of reasons pharma companies have started making this shift. The post Why do Pharma Companies Outsource Pharmaceutical Packaging?

Packaging 52

Packaging Packaging Pharma Companies Contract Packaging 52

Pharmaceutical Technology

SEPTEMBER 2, 2022

The rate of drug approvals could be on the rise. In a recent report, GlobalData revealed that the US Food and Drug Administration (FDA) approved 122 new drug applications (NDAs) and biologic license applications (BLAs) in 2021. There are many reasons why a company might prefer to keep commercialisation activities inhouse.

Drugs 130

Drugs Pharma Companies Sales Production 130

Drug Channels

OCTOBER 14, 2022

Today’s guest post comes from Steve Callahan, Senior Manager of Market Research at MMIT. d/b/a Drug Channels Institute. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. To learn more, check out MMIT’s Strategic Launch Report & Evaluate Forecast solution.

Pharma Companies 79

Pharma Companies Marketing Drugs Research 79

FDA Law Blog

AUGUST 6, 2021

We are similarly at a loss to understand the purpose of Facebook’s new policy requiring that pharmaceutical manufacturers, telehealth companies, and online pharmacies apply for permission to advertise on Facebook. The new policy restricts advertising prescription drugs to the three types of entities mentioned above. So far, so good.

Pharmacy 98

Pharmacy Pharma Companies Drugs Production 98

World of DTC Marketing

DECEMBER 9, 2021

LEAD IN: Pharma budgets are being scrutinized like never before, and DTC/HCP marketers must justify every dollar spent. Cutting through the noise is getting more challenging, and a “mass market” approach doesn’t work anymore unless you have a broad patient population. Digital advertising will account for 64.4%

Drugs 204

Drugs Branding Marketing Production 204

pharmaphorum

MAY 3, 2022

Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai. The class as a whole is, however, trying to break into a low-cost generic market, and almost inevitably is facing pushback from payers.

Marketing 80

Marketing Drugs Sales Pharma Companies 80

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Other businesses such as Redhill Biopharma or Vincerx Pharma have also announced plans for large layoffs. This is particularly felt among smaller retail investors.

Marketing 162

Marketing Gene Therapy Manufacturing Pharma Companies 162

pharmaphorum

SEPTEMBER 22, 2021

When the pandemic emerged, there was an urgent need for quick decisions and swift adaptability while continuing to ensure the safety of employees and limited disruption of the manufacturing and supply chain for much needed and potentially lifesaving drugs for patients.

Pharma Companies 101

Pharma Companies Life Science Development Production 101

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

World of DTC Marketing

FEBRUARY 7, 2022

What has/is happening at Biogen is a train wreck, and the only way to correct this disaster is to tear it down and rebuild the company from the top down. ” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales). Click to Tweet.

Pharma Companies 253

Pharma Companies Marketing Sales Clinical Trials 253

World of DTC Marketing

APRIL 5, 2022

Pharma companies have been investing deeply into digital advertising but vastly under measuring customer engagement and other metrics. Too many marketers rely on metrics that don’t mean a damn thing, like visitors to your website. HCP marketing is changing very quickly.

Production 196

Production Pharma Companies Branding Marketing 196

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

pharmaphorum

JULY 8, 2022

The pharmaceutical industry is increasingly relying on artificial intelligence to power its drug discovery and development efforts, and its spend in this area has created a multibillion-dollar market for AI technologies. The post Pharma’s spend on AI in drug discovery ‘could top $3bn by 2025’ appeared first on.

Drugs 124

Drugs Clinical Development Marketing Genome 124

Pharmaceutical Technology

JUNE 15, 2023

AI for drug development is rapidly streamlining R&D processes, speeding up time to market and providing a better experience for patients and providers. Learn more about the role of AI in drug development and how healthcare researchers are using it to shake up the field.

Development 130

Development Drugs Clinical Trials Clinical Trials 130

World of DTC Marketing

FEBRUARY 21, 2022

Experts across the board are predicting demand for antiviral drugs will rapidly outpace supply. Pfizer and Merck have chosen to designate a select few generic manufacturers to produce cheaper versions of their drugs through the Medicines Patent Pool (MPP). Reportedly, the cost of production for molnupiravir stands at about $17.74.

Regulation 218

Regulation Drugs Bioequivalency Pharmacy 218

STAT News

MARCH 10, 2023

By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products. Continue to STAT+ to read the full story…

Drugs 98

Drugs Pharma Companies Research Production 98

World of DTC Marketing

FEBRUARY 25, 2022

billion on Thursday for allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp, which the drugmaker bought in 2019. Food and Drug Administration approval for the non-Hodgkin lymphoma drug by a Dec. Food and Drug Administration approval for the non-Hodgkin lymphoma drug by a Dec.

Drugs 216

Drugs Sales Pharma Companies Manufacturing 216

World of DTC Marketing

JULY 21, 2022

Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. Despite the number of DTC conferences, there isn’t any one magic formula for successful DTC marketing. The MS market is a great example. DTC marketers seem to ignore this data. It’s not more T.V.

Marketing 266

Marketing Drugs Pharma Companies Doctors 266

World of DTC Marketing

AUGUST 9, 2021

86% of diagnostic device companies, 65% of pharma marketers, and over half of biotechs use social as a critical part of their marketing mix to reach HCPs. HCPs don’t necessarily want pharma trying to sell products via social media. Doximity was flagged for having anti-vaccine information.

Nurses 294

Nurses Marketing Pharma Companies Production 294

World of DTC Marketing

MARCH 18, 2021

This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs. Some patients love the brand of prescription drugs they take because simply “they work” Pharma companies do study brand names, but that’s only about the overall branding of the product.

Branding 180

Branding Pharma Companies Pharma Production Drugs 180

pharmaphorum

APRIL 30, 2021

It’s fair to say this is the most interesting time ever for market access. Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks.

Marketing 82

Marketing Sales Regulation Drugs 82

World of DTC Marketing

JANUARY 18, 2022

Tik-Tok, Instagram, and other social media channels may soon be overwhelmed with pharma companies’ content, but is it a good idea? Pharma companies have policies that heavily restrict their use of social media and limit their ability to benefit from the wealth of data that could accompany it.

Branding 238

Branding Pharma Companies Marketing Production 238